Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies

DOI10.1111/1541-0420.00047zbMath1210.62207OpenAlexW2090107731WikidataQ52010735 ScholiaQ52010735MaRDI QIDQ3079128

Nigel Stallard

Publication date: 1 March 2011

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1111/1541-0420.00047

zbMATH Keywords

optimal stoppingbackward inductioncost-benefit analysissequential procedure

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Bayesian problems; characterization of Bayes procedures (62C10) Medical applications (general) (92C50)

Related Items (1)

Decision‐theoretic designs for a series of trials with correlated treatment effects using the Sarmanov multivariate beta‐binomial distribution

Uses Software

• NAG
• nag

Cites Work

• A Bayesian Decision Approach for Sample Size Determination in Phase II Trials
• Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology
• One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach
• Sample Size Determination for Phase II Clinical Trials Based on Bayesian Decision Theory
• Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes
• Practical Bayesian Guidelines for Phase IIB Clinical Trials
• Design and Analysis of Phase II Cancer Trials: A Review of Statistical Methods and Guidelines for Medical Researchers
• Unnamed Item
• Unnamed Item
• Unnamed Item

This page was built for publication: Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies